ArticleScientific reports2016

A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.

Mei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.